MYEBOGA Conversations Ep 9 The Shea Prueger Interview Expectations and Inclusion

Shea Prueger – Expectations & Inclusion


Shea Prueger was introduced to ibogaine therapy by Eric Taub who she met while seeking treatment for suboxone addiction in 2010 while working as a full time fashion model. Following her own transformation, Shea began an apprenticeship under Lex Kogan at I Begin Again’s ibogaine facility in Guatemala and then Costa Rica, eventually taking over as director of the center.

Shea Prueger has ...

Continue Reading →

MINDCURE Discovers Potential Opportunity for Ibogaine-Assisted Psychotherapy to Treat Neuropathic Pain and Traumatic Brain Injury


This potential treatment opportunity was confirmed by the company’s bioinformatics platform, PsyCollage

VANCOUVER, BC, March 4, 2021 /PRNewswire/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”) a leader in developing technology to advance psychedelic-related treatments, is pleased to announce that the Company’s bioinformatics platform, PsyCollage, has identified opportunities for ibogaine to support neuroregenerative pathways that the Company believes could be pivotal in treating neuropathic pain and ...

Continue Reading →

Missouri Bill Would Add Psychedelics to ‘Right to Try’ Law


Missouri Republican state Rep. Michael Davis last week introduced a measure to expand the state’s Right to Try statute to include Schedule I investigational drugs, including psilocybin, MDMA, LSD, mescaline, ibogaine, and DMT. The drugs would only be available after all other treatment options have been exhausted.

The Right to Try Law, enacted in the state in 2014, allows patients with terminal ...

Continue Reading →
Page 1 of 84 12345...»